$XRTXF Add Anthony J. Giovinazzo XORTX’s two k
Post# of 103059
Add Anthony J. Giovinazzo
XORTX’s two key programs in autosomal dominant polycystic #kidneydisease (ADPKD) and the treatment of acute kidney injury due to #coronavirus COVID-19 infection are advancing toward clinical trial initiation https://finance.yahoo.com/news/xortx-announce...10595.html